Clinical Study on High-fiber Diet and Short-term Fasting in Melanoma Under Immunotherapy With Checkpoint Inhibition

The treatment of melanoma has improved significantly in recent years. A modern form of cancer treatment known as immunotherapy with checkpoint inhibitors plays a key role in this. These drugs help the immune system better recognize and fight cancer cells. Nevertheless, it remains a challenge to maximize treatment effectiveness while minimizing side effects. One possible approach to influencing treatment efficacy and tolerability is diet. A high-fiber diet, as recommended by the German Nutrition Society, increases the effectiveness of immunotherapy, in part through its influence on gut bacteri

Trial Details

NCT ID

NCT07680452

Phase

Sponsor

Charite University, Berlin, Germany

Status

RECRUITING

Cancer Type

Melanoma

Interventions

High-Fiber Diet
High-Fiber Diet and Short-Term Fasting

Locations (sample)

Berlin, State of Berlin, Germany|52.52437,13.41053

Key Eligibility Criteria

Histologically or cytologically confirmed stage IIB-IIIC melanoma
Indication for immune checkpoint inhibition as monotherapy as determined by the tumor board
No prior systemic melanoma therapy
ECOG 0 or 1

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Melanoma Trials on Trialify →